George Morstyn

Amsterdam Molecular Therapeutics (AMT) Holding NV engages in the development of human gene based therapies. The company has a product pipeline of several gene therapy products in development for hemophilia B, acute intermittent porphyria, Parkinson's disease and SanfilippoB. It is expected to be finally dissolved in September 2012. Amsterdam Molecular Therapeutics (AMT) Holding was founded by Sander J. H. van Deventer and John J. P. Kastelein on March 20, 1998 and is headquartered in Amsterdam, Netherlands.

Australian Institute of Co. Directors is a non-profit organization that provides leadership on director issues. It offers governance education, director development, and advocacy. The organization was founded in January 1, 1990 and is headquartered in Sydney, Australia.

Ludwig Institute For Cancer Research Ltd. is non-profit organization engages in the prevention and control of cancer through researches, integrated laboratory and clinical trials. The firm operates in the areas of cell biology, genomics, immunology, neuroscience, signaling, stem cells, therapeutic, tumor biology, brain and breast cancer, immunotherapy, and melanoma. The company was founded by Daniel K. Ludwig in 1971 and is headquartered in New York, NY.

Glykoz Pharma Discovery Pty Ltd. develops carbohydrate based drugs. It also develops drug candidates for licensing to international biotechnology and pharmaceutical companies. The company was founded by Andrew Loch, Ross Coppel, Karyn Joyner, Mark von Itzstein and Richard J. McElhinney on 5 December, 2006 and is headquartered in Nerang, Australia.

Victorian Comprehensive Cancer Centre Pty Ltd. operates as a cancer research, treatment and education centre. The company was founded in 2009 and is headquartered in Melbourne, Australia.